Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea · Delayed Price · Currency is KRW 5,090.00
-70.00 (-1.36%)
Feb 27, 2026, 3:30 PM KST
Bio Plus Market Cap
Bio Plus has a market cap or net worth of 313.24 billion as of February 27, 2026. Its market cap has decreased by -13.38% in one year.
Market Cap
313.24B
Enterprise Value
359.05B
Revenue
96.80B
Ranking
n/a
PE Ratio
21.40
Stock Price
5,090.00
Market Cap Chart
Since September 27, 2021, Bio Plus's market cap has decreased from 451.40B to 313.24B, a decrease of -30.61%. That is a compound annual growth rate of -7.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 313.24B | 1.19% |
| Dec 30, 2025 | 309.55B | -24.79% |
| Dec 30, 2024 | 411.57B | 4.76% |
| Dec 28, 2023 | 392.88B | -2.28% |
| Dec 29, 2022 | 402.04B | 1.78% |
| Dec 30, 2021 | 395.00B | -12.50% |
| Sep 27, 2021 | 451.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curexo | 705.52B |
| WON TECH | 687.33B |
| i-SENS | 679.13B |
| ToolGen | 437.70B |
| InBody Co.,Ltd | 408.44B |
| DRTECH | 174.05B |
| T&R Biofab | 155.08B |
| Osang Healthcare Co.,Ltd | 148.78B |